Security key
74365U107
Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA)
CUSIP: 74365U107
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 5,478,113
- Total 13F value
- $14,679,319
- Share change
- -178,723
- Put/Call ratio
- 88%
- SEC-reported price per share
- $2.68
- Number of holders
- 29
- Value change
- -$481,288
- Number of buys
- 7
- Number of sells
- 9
- Shares outstanding
- 56,174,316
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
29
Top holders
10
TARA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Protara Therapeutics, Inc. SEC filings
Protara Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74365U107
Recent filing periods:
Ownership snapshot
Top reported holders of TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Opaleye Management Inc.
Disclosed value leader
Opaleye Management Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
Lead comparable stake: 4.8%
Showing 1-6 of 15 holder rows.
Quick read
Opaleye Management Inc. leads the comparable SEC ownership view at 4.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Opaleye Management Inc.'s linked filing trail.
Comparable ownership
Top 5
Opaleye Management Inc.
4.8%
ORBIMED ADVISORS LLC
1.5%
VANGUARD GROUP INC
0.76%
PERCEPTIVE ADVISORS LLC
0.52%
Boxer Capital, LLC
0.37%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Opaleye Management Inc. |
13F
Company
|
4.8%
|
$7,993,000
2,708,067 shares
|
— | 30 Sep 2022 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.5%
|
$2,459,000
830,641 shares
|
— | 30 Sep 2022 |
| VANGUARD GROUP INC |
13F
Company
|
0.76%
|
$1,265,000
427,388 shares
|
— | 30 Sep 2022 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
0.52%
|
$859,000
290,051 shares
|
— | 30 Sep 2022 |
| Boxer Capital, LLC |
13F
Company
|
0.37%
|
$619,000
209,227 shares
|
— | 30 Sep 2022 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
0.36%
|
$591,000
199,671 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
29
Shares
5,478,113
Rows available
29
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
26
Q4 2022 holders
29
Holder diff
3
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend